Nov 1, 2023 | BPA Press Release
LONDON-UK – 1st November 2023 marks five years since the UK government legalised cannabis-based products for medicinal use in 2018. British companies are now coming to the fore in creating a UK-based supply chain and R&D programme to support a...
Oct 30, 2023 | Glass Pharms
PRESS RELEASE Monday October 30th For immediate release 1st November this year marks five years since the UK government legalised cannabis-based products for medicinal use in 2018 and figures released by the Home Office this week have shown that the amount of...
Aug 30, 2023 | Celadon Pharmaceuticals
A woman from Bristol who has chronic pain conditions says taking part in a medicinal cannabis trial has “changed her life.” Andrea Wright was just 33 when she had to retire from her job due to ill health. She then discovered the trial, which is looking...
Aug 3, 2023 | Celadon Pharmaceuticals
Celadon Pharmaceuticals, a West Midlands business focused on the research, cultivation, manufacturing and sale of cannabis-based medicines, has received final approval from the NHS for its non-cancer chronic pain clinical trial. The trial, to be conducted at...
May 25, 2023 | Celadon Pharmaceuticals
West Midlands Mayor, Andy Street, has visited Celadon Pharmaceuticals Plc, a West Midlands based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based medicines. During his tour around Celadon’s 100,000 sq...
